MicroRNAs: Turning the Tide in Testicular Cancer

Nirmish Singla, John T. Lafin, Aditya Bagrodia

Research output: Contribution to journalEditorial

4 Scopus citations

Abstract

MicroRNAs are poised to radically change the way we care for patients with germ cell tumors (GCTs) across all disease states, from diagnosis to managing chemorefractory disease. miR-371a-3p is a promising candidate biomarker that may precisely individualize GCT treatment paradigms.

Original languageEnglish (US)
JournalEuropean urology
DOIs
StatePublished - Jan 1 2019

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'MicroRNAs: Turning the Tide in Testicular Cancer'. Together they form a unique fingerprint.

  • Cite this